CATALOGO DEI PRODOTTI DELLA RICERCA

Maggino, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.609
EU - Europa 1.390
AS - Asia 551
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 4
OC - Oceania 2
Totale 3.566
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.607
CN - Cina 522
GB - Regno Unito 454
IE - Irlanda 185
FR - Francia 176
IT - Italia 175
SE - Svezia 159
DE - Germania 110
FI - Finlandia 47
UA - Ucraina 38
BE - Belgio 13
JP - Giappone 12
RU - Federazione Russa 12
IN - India 5
DZ - Algeria 4
KR - Corea 4
NL - Olanda 4
BR - Brasile 3
EU - Europa 3
GR - Grecia 3
AU - Australia 2
CA - Canada 2
DK - Danimarca 2
IR - Iran 2
LV - Lettonia 2
NO - Norvegia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BG - Bulgaria 1
CH - Svizzera 1
EG - Egitto 1
ES - Italia 1
HU - Ungheria 1
ID - Indonesia 1
KG - Kirghizistan 1
KH - Cambogia 1
MA - Marocco 1
MD - Moldavia 1
ME - Montenegro 1
PE - Perù 1
PT - Portogallo 1
SA - Arabia Saudita 1
SG - Singapore 1
TR - Turchia 1
Totale 3.566
Salva come PNG Salva come JPEG
Città #
Southend 438
Chandler 418
Dublin 181
Jacksonville 153
Ashburn 122
Beijing 111
Woodbridge 111
Lawrence 65
Princeton 65
Verona 62
Jinan 55
Houston 54
Redmond 49
Wilmington 45
Nanjing 43
Shenyang 39
Helsinki 29
New York 25
Ann Arbor 24
Haikou 24
Redwood City 23
Tianjin 23
Changsha 19
Hebei 19
Ningbo 19
Sindelfingen 19
Hangzhou 18
Nanchang 17
Seattle 14
Washington 14
Brussels 13
Fairfield 12
Zhengzhou 12
Norwalk 11
Taiyuan 11
Taizhou 11
Fuzhou 9
Lancaster 9
Milan 9
Falkenstein 8
Falls Church 8
Dongguan 6
Jiaxing 6
Pignone 6
Düsseldorf 5
Guangzhou 5
Hyderabad 5
San Francisco 5
Bologna 4
Cagliari 4
Dearborn 4
Des Moines 4
Lappeenranta 4
Minoh 4
Seoul 4
Algiers 3
Chicago 3
Lanzhou 3
Leawood 3
Pawtucket 3
Pozzo Di Gotto 3
Riva 3
Tokyo 3
Amsterdam 2
Athens 2
Curitiba 2
Fabriano 2
Groningen 2
Iglesias 2
Ivrea 2
Lana 2
Mehlingen 2
Pomezia 2
Toronto 2
Yicheng 2
Battipaglia 1
Bergen 1
Bishkek 1
Brierley Hill 1
Budapest 1
Cairo 1
Cambridge 1
Catania 1
Chisinau 1
Cleveland 1
Copenhagen 1
Cupertino 1
Eden Prairie 1
Fremont 1
Gunzenhausen 1
Illasi 1
Isola della Scala 1
Jakarta 1
Kemerovo 1
Kharkov 1
Landshut 1
Lima 1
Lishui 1
London 1
Marburg 1
Totale 2.550
Salva come PNG Salva come JPEG
Nome #
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 109
Results of a surveillance protocol for pancreatic BD-IPMNs 105
Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? 99
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal 97
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 97
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 96
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM 86
Distal pancreatectomy associated with multivisceral resection: results from a single centre experience 86
Solid pseudopapillary tumors of the pancreas: Specific pathological features predict the likelihood of postoperative recurrence 80
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 80
Reappraisal of Nodal Staging and Study of Lymph Node Station Involvement in Pancreaticoduodenectomy with the Standard International Study Group of Pancreatic Surgery Definition of Lymphadenectomy for Cancer 79
Assessment of a complication risk score and study of complication profile in laparoscopic distal pancreatectomy 79
Synchronous superior mesenteric-portal vein resection during pancreatectomy for T3 head adenocarcinoma: Perioperative outcomes and prognostic implications of histologically confirmed venous infiltration 79
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 79
Over 700 Whipples for Pancreaticobiliary Malignancies: Postoperative Morbidity Is an Additional Negative Prognostic Factor for Distal Bile Duct Cancer 77
Pancreatectomy with Para-Aortic Lymph Node Dissection for Pancreatic Head Adenocarcinoma: Pattern of Nodal Metastasis Spread and Analysis of Prognostic Factors 76
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 76
Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas) 70
An unforeseeable adverse event during ERCP 70
Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy: Analysis of 2026 Resections From the International, Multi-institutional Distal Pancreatectomy Study Group 70
International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer 61
Core Set of Patient-reported Outcomes in Pancreatic Cancer (COPRAC) An International Delphi Study Among Patients and Health Care Providers 60
ASO Author Reflections: Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma 60
Analysis and proceeding to full publication of abstracts presented at the Pancreas Club annual meeting 58
Pancreatic Adenocarcinoma 57
Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications 56
Assessing the influence of experience in pancreatic surgery: a risk-adjusted analysis using the American College of Surgeons NSQIP database 56
Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma 55
Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort 53
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer 51
Evolving the Paradigm of Early Drain Removal Following Pancreatoduodenectomy 48
Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma 48
Decision-Making for the Management of Cystic Lesions of the Pancreas: How Satisfied Are Patients with Surgery? 45
Defining the practice of distal pancreatectomy around the world 44
Revision of Pancreatic Neck Margins Based on Intraoperative Frozen Section Analysis Is Associated With Improved Survival in Patients Undergoing Pancreatectomy for Ductal Adenocarcinoma 44
The Beneficial Effects of Minimizing Blood Loss in Pancreatoduodenectomy 43
Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma? 43
Trends in practice patterns and outcomes: A decade of sarcoma care in the United States 43
The Sequential Radiographic Effects of Preoperative Chemotherapy and (Chemo)Radiation on Tumor Anatomy in Patients with Localized Pancreatic Cancer 43
Intraductal Papillary Mucinous Neoplasm Around the World 42
Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies 42
Identification of an Optimal Cut-off for Drain Fluid Amylase on Postoperative Day 1 for Predicting Clinically Relevant Fistula After Distal Pancreatectomy: A Multi-institutional Analysis and External Validation 40
Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis 40
ASO Visual Abstract: Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective Lymphadenectomy Protocol 40
Defining the Safety Profile for Performing Pancreatoduodenectomy in the Setting of Hyperbilirubinemia 39
Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis 38
Surgical experience and the practice of pancreatoduodenectomy 38
Extended Experience with a Dynamic, Data-Driven Selective Drain Management Protocol in Pancreaticoduodenectomy: Progressive Risk Stratification for Better Practice 38
Response to: Managing the High-risk Pancreatic Anastomosis 37
Response to Comment on "Reappraising the Concept of Conditional Survival After Pancreatectomy for Ductal Adenocarcinoma" 36
Impact of Operative Time on Outcomes after Pancreatic Resection: A Risk-Adjusted Analysis Using the American College of Surgeons NSQIP Database 34
ASO Author Reflection: Location of Nodal Metastases in Pancreatoduodenectomy for Cancer: Which Station Matters? 34
Reappraising the Concept of Conditional Survival After Pancreatectomy for Ductal Adenocarcinoma: A Bi-institutional Analysis 33
CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 33
Respect - A multicenter retrospective study on preoperative chemotherapy in locally advanced and borderline resectable pancreatic cancer 32
The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms 29
Number of Examined Lymph Nodes and Nodal Status Assessment in Distal Pancreatectomy for Body/Tail Ductal Adenocarcinoma 28
Long-term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma 28
ASO Visual Abstract: Ca 19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 27
Pasireotide for the Prevention of Postoperative Pancreatic Fistula: Time to Curb the Enthusiasm? 26
Pancreatic Head Resection Following Roux-en-Y Gastric Bypass: Operative Considerations and Outcomes 26
Reappraisal of a 2-Cm Cut-Off Size for the Management of Cystic Pancreatic Neuroendocrine Neoplasms: A Multicenter International Study 26
Response to: "Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation" 25
Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma 25
Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective, Lymphadenectomy Protocol 25
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring / Poorly Cohesive Cells 24
Taking Theory to Practice: Quality Improvement for Pancreaticoduodenectomy and Development and Integration of the Fistula Risk Score 23
Pancreatic ductal adenocarcinoma: time for a neoadjuvant revolution? 23
Forecasting surgical costs: Towards informed financial consent and financial risk reduction 23
A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma 21
Verona Evidence-Based Meeting (EBM) 2020 on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: Meeting Report 14
The Influence of Intraoperative Blood Loss on Fistula Development Following Pancreatoduodenectomy 13
The Fistula Risk Score Catalog: Toward Precision Medicine for Pancreatic Fistula After Pancreatoduodenectomy 12
Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy 12
ASO Author Reflections: Recurrence Following Post-neoadjuvant Pancreatectomy: How Can We Do Better? 4
ASO Visual Abstract: FOLFIRINOX or Gemcitabine Based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-Institutional, Patient-Level Meta-Analysis and Systematic Review 4
Outcomes of rescue procedures in the management of locally recurrent ampullary tumors: A Pancreas 2000/EPC study 2
FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review 1
Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: a retrospective, multicenter analysis 1
Totale 3.696
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.003
article - articoli 13.536
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 286
patent - brevetti 0
selected - selezionate 0
volume - volumi 181
Totale 28.006
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201910 0 0 0 0 0 0 0 0 0 3 4 3
2019/2020408 38 2 5 8 119 69 41 6 9 27 24 60
2020/2021548 89 85 19 86 62 83 29 5 13 16 44 17
2021/2022459 45 120 10 24 10 10 12 33 29 16 32 118
2022/20231.168 71 139 102 195 100 300 30 79 106 11 22 13
2023/2024523 26 64 64 65 67 115 54 42 14 12 0 0
Totale 3.696